

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | linoleic acid metabolic process (GO:0043651) | 9.72398047 |
| 2 | hair follicle morphogenesis (GO:0031069) | 8.22106037 |
| 3 | intermediate filament cytoskeleton organization (GO:0045104) | 7.83531990 |
| 4 | intermediate filament-based process (GO:0045103) | 7.60288393 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.46675074 |
| 6 | L-phenylalanine catabolic process (GO:0006559) | 7.46675074 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.11467450 |
| 8 | L-phenylalanine metabolic process (GO:0006558) | 7.11467450 |
| 9 | aromatic amino acid family catabolic process (GO:0009074) | 7.01737370 |
| 10 | keratinocyte proliferation (GO:0043616) | 6.74097330 |
| 11 | tryptophan catabolic process (GO:0006569) | 6.66443455 |
| 12 | indole-containing compound catabolic process (GO:0042436) | 6.66443455 |
| 13 | indolalkylamine catabolic process (GO:0046218) | 6.66443455 |
| 14 | multicellular organismal water homeostasis (GO:0050891) | 6.62584536 |
| 15 | bile acid biosynthetic process (GO:0006699) | 6.59297739 |
| 16 | peptide cross-linking (GO:0018149) | 6.55050576 |
| 17 | kynurenine metabolic process (GO:0070189) | 6.46126927 |
| 18 | retinol metabolic process (GO:0042572) | 6.44607451 |
| 19 | epidermis development (GO:0008544) | 6.36629388 |
| 20 | tryptophan metabolic process (GO:0006568) | 6.22278712 |
| 21 | glyoxylate metabolic process (GO:0046487) | 6.11065424 |
| 22 | complement activation, alternative pathway (GO:0006957) | 6.08340699 |
| 23 | keratinocyte differentiation (GO:0030216) | 6.06129550 |
| 24 | regulation of protein activation cascade (GO:2000257) | 5.92164202 |
| 25 | regulation of sequestering of triglyceride (GO:0010889) | 5.90227385 |
| 26 | alpha-linolenic acid metabolic process (GO:0036109) | 5.85390172 |
| 27 | long-chain fatty acid biosynthetic process (GO:0042759) | 5.75851757 |
| 28 | water homeostasis (GO:0030104) | 5.73400123 |
| 29 | regulation of complement activation (GO:0030449) | 5.67038677 |
| 30 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.64452706 |
| 31 | urea cycle (GO:0000050) | 5.64452492 |
| 32 | urea metabolic process (GO:0019627) | 5.64452492 |
| 33 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.55055773 |
| 34 | * fatty acid elongation (GO:0030497) | 5.50105647 |
| 35 | cysteine metabolic process (GO:0006534) | 5.44367358 |
| 36 | sulfur amino acid catabolic process (GO:0000098) | 5.41222700 |
| 37 | negative regulation of fibrinolysis (GO:0051918) | 5.39966938 |
| 38 | regulation of fibrinolysis (GO:0051917) | 5.33109658 |
| 39 | bile acid metabolic process (GO:0008206) | 5.30358653 |
| 40 | protein carboxylation (GO:0018214) | 5.25503013 |
| 41 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.25503013 |
| 42 | nitrogen cycle metabolic process (GO:0071941) | 5.19354625 |
| 43 | lipoxygenase pathway (GO:0019372) | 5.08176399 |
| 44 | aromatic amino acid family metabolic process (GO:0009072) | 5.07763588 |
| 45 | molting cycle process (GO:0022404) | 5.03421344 |
| 46 | hair cycle process (GO:0022405) | 5.03421344 |
| 47 | high-density lipoprotein particle remodeling (GO:0034375) | 5.00899044 |
| 48 | serine family amino acid catabolic process (GO:0009071) | 5.00846686 |
| 49 | * long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 5.00416670 |
| 50 | primary alcohol metabolic process (GO:0034308) | 5.00269909 |
| 51 | epidermal cell differentiation (GO:0009913) | 4.92439829 |
| 52 | homocysteine metabolic process (GO:0050667) | 4.92373766 |
| 53 | coenzyme catabolic process (GO:0009109) | 4.85559181 |
| 54 | cytolysis (GO:0019835) | 4.84897009 |
| 55 | regulation of triglyceride catabolic process (GO:0010896) | 4.83234694 |
| 56 | lysine catabolic process (GO:0006554) | 4.75089466 |
| 57 | lysine metabolic process (GO:0006553) | 4.75089466 |
| 58 | indolalkylamine metabolic process (GO:0006586) | 4.69411870 |
| 59 | tyrosine metabolic process (GO:0006570) | 4.63324496 |
| 60 | alpha-amino acid catabolic process (GO:1901606) | 4.62555311 |
| 61 | low-density lipoprotein particle clearance (GO:0034383) | 4.61834931 |
| 62 | amine catabolic process (GO:0009310) | 4.59713773 |
| 63 | cellular biogenic amine catabolic process (GO:0042402) | 4.59713773 |
| 64 | bile acid and bile salt transport (GO:0015721) | 4.56569153 |
| 65 | glycine metabolic process (GO:0006544) | 4.54232475 |
| 66 | acylglycerol homeostasis (GO:0055090) | 4.51219129 |
| 67 | triglyceride homeostasis (GO:0070328) | 4.51219129 |
| 68 | ethanol oxidation (GO:0006069) | 4.50644973 |
| 69 | * very long-chain fatty acid metabolic process (GO:0000038) | 4.50561562 |
| 70 | amino-acid betaine metabolic process (GO:0006577) | 4.50021312 |
| 71 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 4.48104033 |
| 72 | positive regulation of chemokine secretion (GO:0090197) | 4.39881936 |
| 73 | reverse cholesterol transport (GO:0043691) | 4.37744766 |
| 74 | protein-lipid complex remodeling (GO:0034368) | 4.35394522 |
| 75 | macromolecular complex remodeling (GO:0034367) | 4.35394522 |
| 76 | plasma lipoprotein particle remodeling (GO:0034369) | 4.35394522 |
| 77 | imidazole-containing compound metabolic process (GO:0052803) | 4.34844572 |
| 78 | positive regulation of keratinocyte differentiation (GO:0045618) | 4.31601435 |
| 79 | hemidesmosome assembly (GO:0031581) | 4.30580901 |
| 80 | serine family amino acid metabolic process (GO:0009069) | 4.28421400 |
| 81 | cellular amino acid catabolic process (GO:0009063) | 4.27486847 |
| 82 | complement activation, classical pathway (GO:0006958) | 4.23604988 |
| 83 | regulation of cholesterol esterification (GO:0010872) | 4.21731813 |
| 84 | phospholipid efflux (GO:0033700) | 4.20860338 |
| 85 | benzene-containing compound metabolic process (GO:0042537) | 4.20667440 |
| 86 | glutamate metabolic process (GO:0006536) | 4.19417998 |
| 87 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.18895732 |
| 88 | cellular ketone body metabolic process (GO:0046950) | 4.18467780 |
| 89 | regulation of chemokine secretion (GO:0090196) | 4.17609168 |
| 90 | acetyl-CoA metabolic process (GO:0006084) | 4.16888312 |
| 91 | cellular glucuronidation (GO:0052695) | 4.12376886 |
| 92 | complement activation (GO:0006956) | 4.11988387 |
| 93 | cellular modified amino acid catabolic process (GO:0042219) | 4.11607999 |
| 94 | * fatty-acyl-CoA metabolic process (GO:0035337) | 4.11397333 |
| 95 | plasma lipoprotein particle clearance (GO:0034381) | 4.10804772 |
| 96 | serine family amino acid biosynthetic process (GO:0009070) | 4.09981711 |
| 97 | response to phenylpropanoid (GO:0080184) | 4.06638456 |
| 98 | negative regulation of cholesterol transport (GO:0032375) | 4.04353933 |
| 99 | negative regulation of sterol transport (GO:0032372) | 4.04353933 |
| 100 | fibrinolysis (GO:0042730) | 4.03755981 |
| 101 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.03593568 |
| 102 | aldehyde catabolic process (GO:0046185) | 3.94467972 |
| 103 | cofactor catabolic process (GO:0051187) | 3.91683280 |
| 104 | protein activation cascade (GO:0072376) | 3.91645791 |
| 105 | cholesterol efflux (GO:0033344) | 3.89901754 |
| 106 | arginine metabolic process (GO:0006525) | 3.85408060 |
| 107 | blood coagulation, intrinsic pathway (GO:0007597) | 3.78062294 |
| 108 | organic acid catabolic process (GO:0016054) | 3.76129354 |
| 109 | carboxylic acid catabolic process (GO:0046395) | 3.76129354 |
| 110 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 3.75807028 |
| 111 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.74931319 |
| 112 | plasma lipoprotein particle assembly (GO:0034377) | 3.73187263 |
| 113 | phospholipid homeostasis (GO:0055091) | 3.72050378 |
| 114 | regulation of cholesterol homeostasis (GO:2000188) | 3.70873686 |
| 115 | carnitine metabolic process (GO:0009437) | 3.68669026 |
| 116 | low-density lipoprotein particle remodeling (GO:0034374) | 3.66588362 |
| 117 | uronic acid metabolic process (GO:0006063) | 3.65613133 |
| 118 | glucuronate metabolic process (GO:0019585) | 3.65613133 |
| 119 | NAD biosynthetic process (GO:0009435) | 3.62305148 |
| 120 | * long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.62046312 |
| 121 | ketone body metabolic process (GO:1902224) | 3.61932355 |
| 122 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.61883850 |
| 123 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.61883850 |
| 124 | positive regulation of epidermal cell differentiation (GO:0045606) | 3.60145975 |
| 125 | cholesterol homeostasis (GO:0042632) | 3.59070201 |
| 126 | positive regulation of lipid catabolic process (GO:0050996) | 3.58462039 |
| 127 | fatty acid beta-oxidation (GO:0006635) | 3.57289567 |
| 128 | fatty acid oxidation (GO:0019395) | 3.56896742 |
| 129 | response to nitrosative stress (GO:0051409) | 3.56783262 |
| 130 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.55808043 |
| 131 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.55808043 |
| 132 | short-chain fatty acid metabolic process (GO:0046459) | 3.53951830 |
| 133 | sterol homeostasis (GO:0055092) | 3.53048763 |
| 134 | monocarboxylic acid catabolic process (GO:0072329) | 3.52849380 |
| 135 | * fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.51920320 |
| 136 | * triglyceride biosynthetic process (GO:0019432) | 3.48730011 |
| 137 | lipid storage (GO:0019915) | 3.47067156 |
| 138 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 3.45679796 |
| 139 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 3.45583436 |
| 140 | primary alcohol catabolic process (GO:0034310) | 3.45186665 |
| 141 | skin morphogenesis (GO:0043589) | 3.39592512 |
| 142 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 3.38635393 |
| 143 | * neutral lipid biosynthetic process (GO:0046460) | 3.26997077 |
| 144 | * acylglycerol biosynthetic process (GO:0046463) | 3.26997077 |
| 145 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.26487269 |
| 146 | phosphatidylcholine acyl-chain remodeling (GO:0036151) | 3.21605099 |
| 147 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 3.21561041 |
| 148 | phosphatidic acid metabolic process (GO:0046473) | 3.21039189 |
| 149 | phosphatidic acid biosynthetic process (GO:0006654) | 3.21039189 |
| 150 | regulation of keratinocyte differentiation (GO:0045616) | 3.13062590 |
| 151 | * acyl-CoA biosynthetic process (GO:0071616) | 3.10944957 |
| 152 | * thioester biosynthetic process (GO:0035384) | 3.10944957 |
| 153 | fatty acid homeostasis (GO:0055089) | 3.09241147 |
| 154 | regulation of defense response to virus by host (GO:0050691) | 3.08070236 |
| 155 | positive regulation of epidermis development (GO:0045684) | 3.04987791 |
| 156 | defense response to fungus (GO:0050832) | 3.03535991 |
| 157 | molting cycle (GO:0042303) | 23.9934878 |
| 158 | hair cycle (GO:0042633) | 23.9934878 |
| 159 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.94620288 |
| 160 | * acyl-CoA metabolic process (GO:0006637) | 2.94349329 |
| 161 | * thioester metabolic process (GO:0035383) | 2.94349329 |
| 162 | unsaturated fatty acid biosynthetic process (GO:0006636) | 2.92805087 |
| 163 | epithelium development (GO:0060429) | 2.92141148 |
| 164 | adhesion of symbiont to host cell (GO:0044650) | 2.81607770 |
| 165 | virion attachment to host cell (GO:0019062) | 2.81607770 |
| 166 | positive regulation of lipid storage (GO:0010884) | 2.81603998 |
| 167 | regulation of phospholipase A2 activity (GO:0032429) | 2.81265007 |
| 168 | ethanol metabolic process (GO:0006067) | 2.80462959 |
| 169 | phosphatidylserine metabolic process (GO:0006658) | 2.78825805 |
| 170 | disruption of cells of other organism (GO:0044364) | 2.78460030 |
| 171 | killing of cells of other organism (GO:0031640) | 2.78460030 |
| 172 | regulation of retinoic acid receptor signaling pathway (GO:0048385) | 2.72126952 |
| 173 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.63612394 |
| 174 | hair follicle development (GO:0001942) | 2.61665641 |
| 175 | adhesion of symbiont to host (GO:0044406) | 2.52850173 |
| 176 | alditol phosphate metabolic process (GO:0052646) | 2.52116290 |
| 177 | triglyceride catabolic process (GO:0019433) | 2.49036865 |
| 178 | polarized epithelial cell differentiation (GO:0030859) | 2.48303966 |
| 179 | oocyte development (GO:0048599) | 2.43061600 |
| 180 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.40474133 |
| 181 | regulation of epidermal cell differentiation (GO:0045604) | 2.37412711 |
| 182 | ectoderm development (GO:0007398) | 2.36864864 |
| 183 | response to insecticide (GO:0017085) | 2.27569753 |
| 184 | regulation of hypersensitivity (GO:0002883) | 2.25402370 |
| 185 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.24996915 |
| 186 | one-carbon compound transport (GO:0019755) | 2.23027663 |
| 187 | negative regulation of lipase activity (GO:0060192) | 2.21888997 |
| 188 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.21014937 |
| 189 | glycerol metabolic process (GO:0006071) | 2.17097262 |
| 190 | alditol metabolic process (GO:0019400) | 2.14737715 |
| 191 | detection of bacterium (GO:0016045) | 2.14304191 |
| 192 | intermediate filament organization (GO:0045109) | 13.0067521 |
| 193 | establishment of skin barrier (GO:0061436) | 11.8333542 |
| 194 | keratinization (GO:0031424) | 11.5244909 |
| 195 | regulation of water loss via skin (GO:0033561) | 10.2781194 |
| 196 | desmosome organization (GO:0002934) | 10.1657165 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 8.88743920 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.21001656 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.22380931 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.17357263 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.40612674 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.24232015 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.84841224 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.81701409 |
| 9 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 4.53021312 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.12298743 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.73935366 |
| 12 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 3.21016448 |
| 13 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.68675078 |
| 14 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.28828354 |
| 15 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 2.22940185 |
| 16 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.09207872 |
| 17 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.01850109 |
| 18 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.00403500 |
| 19 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.8780955 |
| 20 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.95039374 |
| 21 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.82450196 |
| 22 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.71389554 |
| 23 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.58781991 |
| 24 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.58508855 |
| 25 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.58003600 |
| 26 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.54631842 |
| 27 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.54631842 |
| 28 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.51194565 |
| 29 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.48965638 |
| 30 | * HTT_18923047_ChIP-ChIP_STHdh_Human | 1.48526893 |
| 31 | GATA1_22025678_ChIP-Seq_K562_Human | 1.45914572 |
| 32 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.43717355 |
| 33 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.41692377 |
| 34 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.41210283 |
| 35 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.35869211 |
| 36 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.34809258 |
| 37 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.34625316 |
| 38 | * P68_20966046_ChIP-Seq_HELA_Human | 1.26865125 |
| 39 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.26214704 |
| 40 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.22729001 |
| 41 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.20207421 |
| 42 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.12032589 |
| 43 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09915271 |
| 44 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.07597963 |
| 45 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.06350688 |
| 46 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.05254682 |
| 47 | RXR_22108803_ChIP-Seq_LS180_Human | 1.05031731 |
| 48 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.02992637 |
| 49 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.02275746 |
| 50 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.00714523 |
| 51 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.99474718 |
| 52 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.99452083 |
| 53 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.98221154 |
| 54 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.97568744 |
| 55 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.96696217 |
| 56 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.96427606 |
| 57 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.96022122 |
| 58 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.96019312 |
| 59 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.95859028 |
| 60 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.94669485 |
| 61 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.94474022 |
| 62 | * FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.93592198 |
| 63 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.92838220 |
| 64 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.91600597 |
| 65 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.90937112 |
| 66 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.90314891 |
| 67 | ATF3_27146783_Chip-Seq_COLON_Human | 0.89805038 |
| 68 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.89115433 |
| 69 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88831631 |
| 70 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.88827841 |
| 71 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.88445744 |
| 72 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.88180389 |
| 73 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.87483714 |
| 74 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.87046759 |
| 75 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86948297 |
| 76 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.84698628 |
| 77 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.83600828 |
| 78 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.82388982 |
| 79 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.81405252 |
| 80 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.81334929 |
| 81 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.81334929 |
| 82 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.81145812 |
| 83 | TBL1_22424771_ChIP-Seq_293T_Human | 0.80522618 |
| 84 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.78606310 |
| 85 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.78586991 |
| 86 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.78475000 |
| 87 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.78344837 |
| 88 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.77956499 |
| 89 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.77613448 |
| 90 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.77576746 |
| 91 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.77558838 |
| 92 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.76798885 |
| 93 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.76541080 |
| 94 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.75467686 |
| 95 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.75216169 |
| 96 | P300_27268052_Chip-Seq_Bcells_Human | 0.74309317 |
| 97 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.74301500 |
| 98 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.74301500 |
| 99 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.74163435 |
| 100 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.73896072 |
| 101 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.73801832 |
| 102 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.73448688 |
| 103 | * JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.71685338 |
| 104 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.71465479 |
| 105 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.71465479 |
| 106 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.70895151 |
| 107 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.69396682 |
| 108 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.69093663 |
| 109 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.68871652 |
| 110 | * CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.68851817 |
| 111 | SA1_27219007_Chip-Seq_Bcells_Human | 0.68549379 |
| 112 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.68300565 |
| 113 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.67874566 |
| 114 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.67412790 |
| 115 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.64454445 |
| 116 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.64142735 |
| 117 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.62432432 |
| 118 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.61272036 |
| 119 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.60490342 |
| 120 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.59404447 |
| 121 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.57946114 |
| 122 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.57905173 |
| 123 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.57374663 |
| 124 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.56766715 |
| 125 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.56403950 |
| 126 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.56383433 |
| 127 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.56038090 |
| 128 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.55568212 |
| 129 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.54497634 |
| 130 | AR_20517297_ChIP-Seq_VCAP_Human | 0.54335443 |
| 131 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.53604628 |
| 132 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.52406119 |
| 133 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.51166462 |
| 134 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.50206122 |
| 135 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.49886485 |
| 136 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.49744802 |
| 137 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.49510019 |
| 138 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.48656669 |
| 139 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.48438683 |
| 140 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.48154253 |
| 141 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.47916488 |
| 142 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.47402392 |
| 143 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.47297496 |
| 144 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.45147972 |
| 145 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.43385593 |
| 146 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.43196125 |
| 147 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.42219132 |
| 148 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.41848519 |
| 149 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.41696676 |
| 150 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.41327228 |
| 151 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.39868050 |
| 152 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.39517180 |
| 153 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.39286282 |
| 154 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.38564012 |
| 155 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.38212973 |
| 156 | GATA2_19941826_ChIP-Seq_K562_Human | 0.37640109 |
| 157 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.37130136 |
| 158 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.36742912 |
| 159 | NCOR_22424771_ChIP-Seq_293T_Human | 0.36369271 |
| 160 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.36129682 |
| 161 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.35724411 |
| 162 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.35693168 |
| 163 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.34929189 |
| 164 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.34823934 |
| 165 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.34495171 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.29950217 |
| 2 | MP0005360_urolithiasis | 7.39877109 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.63037432 |
| 4 | MP0005365_abnormal_bile_salt | 6.41045194 |
| 5 | * MP0000647_abnormal_sebaceous_gland | 5.24240053 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.49699962 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 4.42080084 |
| 8 | MP0003252_abnormal_bile_duct | 4.16795861 |
| 9 | MP0001188_hyperpigmentation | 3.96950072 |
| 10 | MP0010329_abnormal_lipoprotein_level | 3.56052235 |
| 11 | * MP0005501_abnormal_skin_physiology | 3.44478296 |
| 12 | * MP0000377_abnormal_hair_follicle | 2.98113034 |
| 13 | MP0005083_abnormal_biliary_tract | 2.97100878 |
| 14 | MP0009840_abnormal_foam_cell | 2.87569734 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.68217077 |
| 16 | MP0005332_abnormal_amino_acid | 2.63349094 |
| 17 | * MP0001216_abnormal_epidermal_layer | 2.62200298 |
| 18 | MP0003195_calcinosis | 2.56890855 |
| 19 | MP0010678_abnormal_skin_adnexa | 2.56395909 |
| 20 | MP0002095_abnormal_skin_pigmentation | 2.47581436 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 2.19823753 |
| 22 | MP0000609_abnormal_liver_physiology | 2.17441135 |
| 23 | * MP0010771_integument_phenotype | 2.17273005 |
| 24 | MP0000383_abnormal_hair_follicle | 2.16845049 |
| 25 | MP0002118_abnormal_lipid_homeostasis | 2.12212438 |
| 26 | MP0005409_darkened_coat_color | 2.07856313 |
| 27 | MP0003868_abnormal_feces_composition | 2.07311768 |
| 28 | MP0004019_abnormal_vitamin_homeostasis | 2.01681362 |
| 29 | MP0002138_abnormal_hepatobiliary_system | 1.95764034 |
| 30 | * MP0004947_skin_inflammation | 1.94575386 |
| 31 | MP0000566_synostosis | 1.91529109 |
| 32 | MP0000015_abnormal_ear_pigmentation | 1.89004753 |
| 33 | MP0005319_abnormal_enzyme/_coenzyme | 1.84515713 |
| 34 | MP0009931_abnormal_skin_appearance | 1.77641338 |
| 35 | * MP0004381_abnormal_hair_follicle | 1.75817484 |
| 36 | * MP0000367_abnormal_coat/_hair | 1.68929462 |
| 37 | MP0003011_delayed_dark_adaptation | 1.65228867 |
| 38 | MP0001764_abnormal_homeostasis | 1.60765116 |
| 39 | MP0003300_gastrointestinal_ulcer | 1.59682246 |
| 40 | MP0009697_abnormal_copulation | 1.55424052 |
| 41 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.54253381 |
| 42 | MP0005174_abnormal_tail_pigmentation | 1.52357031 |
| 43 | MP0003705_abnormal_hypodermis_morpholog | 1.47162811 |
| 44 | MP0003878_abnormal_ear_physiology | 1.39253822 |
| 45 | MP0005377_hearing/vestibular/ear_phenot | 1.39253822 |
| 46 | MP0004185_abnormal_adipocyte_glucose | 1.35378692 |
| 47 | MP0005647_abnormal_sex_gland | 1.29881469 |
| 48 | MP0003941_abnormal_skin_development | 1.26473797 |
| 49 | MP0005451_abnormal_body_composition | 1.23313897 |
| 50 | MP0003186_abnormal_redox_activity | 1.21439892 |
| 51 | MP0001191_abnormal_skin_condition | 1.14717478 |
| 52 | MP0000598_abnormal_liver_morphology | 1.14657021 |
| 53 | MP0009643_abnormal_urine_homeostasis | 1.14259753 |
| 54 | MP0003656_abnormal_erythrocyte_physiolo | 1.13250279 |
| 55 | MP0002254_reproductive_system_inflammat | 1.10488136 |
| 56 | MP0000579_abnormal_nail_morphology | 1.04743003 |
| 57 | MP0004885_abnormal_endolymph | 1.00608323 |
| 58 | MP0010368_abnormal_lymphatic_system | 0.99934494 |
| 59 | MP0009764_decreased_sensitivity_to | 0.99930815 |
| 60 | MP0010030_abnormal_orbit_morphology | 0.95485432 |
| 61 | MP0009763_increased_sensitivity_to | 0.95054671 |
| 62 | MP0000604_amyloidosis | 0.92318477 |
| 63 | MP0005636_abnormal_mineral_homeostasis | 0.87872079 |
| 64 | MP0008469_abnormal_protein_level | 0.87512836 |
| 65 | MP0005408_hypopigmentation | 0.84199839 |
| 66 | MP0004858_abnormal_nervous_system | 0.82824135 |
| 67 | MP0009642_abnormal_blood_homeostasis | 0.82434938 |
| 68 | MP0006036_abnormal_mitochondrial_physio | 0.81962529 |
| 69 | MP0004130_abnormal_muscle_cell | 0.81299993 |
| 70 | MP0000762_abnormal_tongue_morphology | 0.80856778 |
| 71 | MP0005220_abnormal_exocrine_pancreas | 0.80829081 |
| 72 | MP0005084_abnormal_gallbladder_morpholo | 0.78707400 |
| 73 | MP0005376_homeostasis/metabolism_phenot | 0.78090340 |
| 74 | MP0002078_abnormal_glucose_homeostasis | 0.75750694 |
| 75 | * MP0002796_impaired_skin_barrier | 0.75540464 |
| 76 | MP0002876_abnormal_thyroid_physiology | 0.75208221 |
| 77 | MP0000569_abnormal_digit_pigmentation | 0.73239905 |
| 78 | MP0002971_abnormal_brown_adipose | 0.72824106 |
| 79 | MP0005670_abnormal_white_adipose | 0.72358194 |
| 80 | MP0005334_abnormal_fat_pad | 0.71872818 |
| 81 | MP0003566_abnormal_cell_adhesion | 0.71226256 |
| 82 | MP0009765_abnormal_xenobiotic_induced | 0.70784748 |
| 83 | MP0009384_cardiac_valve_regurgitation | 0.67650412 |
| 84 | MP0009379_abnormal_foot_pigmentation | 0.67520720 |
| 85 | MP0005266_abnormal_metabolism | 0.67497106 |
| 86 | MP0006035_abnormal_mitochondrial_morpho | 0.64394263 |
| 87 | * MP0005535_abnormal_body_temperature | 0.63611822 |
| 88 | MP0009053_abnormal_anal_canal | 0.61409117 |
| 89 | MP0003690_abnormal_glial_cell | 0.60322423 |
| 90 | MP0002177_abnormal_outer_ear | 0.59239806 |
| 91 | MP0001661_extended_life_span | 0.58123116 |
| 92 | MP0000427_abnormal_hair_cycle | 0.57894334 |
| 93 | MP0000639_abnormal_adrenal_gland | 0.54848816 |
| 94 | MP0005375_adipose_tissue_phenotype | 0.54795925 |
| 95 | MP0003329_amyloid_beta_deposits | 0.54073418 |
| 96 | MP0005448_abnormal_energy_balance | 0.54069700 |
| 97 | MP0001851_eye_inflammation | 0.52637775 |
| 98 | MP0002928_abnormal_bile_duct | 0.51056519 |
| 99 | MP0001756_abnormal_urination | 0.51024920 |
| 100 | MP0002060_abnormal_skin_morphology | 0.50860805 |
| 101 | MP0010234_abnormal_vibrissa_follicle | 0.50307313 |
| 102 | MP0003724_increased_susceptibility_to | 0.49202271 |
| 103 | MP0005166_decreased_susceptibility_to | 0.47489427 |
| 104 | MP0000627_abnormal_mammary_gland | 0.46412333 |
| 105 | MP0005666_abnormal_adipose_tissue | 0.44840316 |
| 106 | MP0004782_abnormal_surfactant_physiolog | 0.44285816 |
| 107 | MP0002837_dystrophic_cardiac_calcinosis | 0.43877824 |
| 108 | MP0002166_altered_tumor_susceptibility | 0.43376412 |
| 109 | MP0001984_abnormal_olfaction | 0.43204348 |
| 110 | * MP0001784_abnormal_fluid_regulation | 0.41423696 |
| 111 | MP0005395_other_phenotype | 0.41396719 |
| 112 | MP0008438_abnormal_cutaneous_collagen | 0.41168055 |
| 113 | MP0002006_tumorigenesis | 0.40823679 |
| 114 | MP0005503_abnormal_tendon_morphology | 0.40553668 |
| 115 | MP0003718_maternal_effect | 0.40465419 |
| 116 | MP0003953_abnormal_hormone_level | 0.37693109 |
| 117 | MP0003453_abnormal_keratinocyte_physiol | 0.37354415 |
| 118 | MP0001243_abnormal_dermal_layer | 0.37246970 |
| 119 | MP0002136_abnormal_kidney_physiology | 0.36952586 |
| 120 | MP0003075_altered_response_to | 0.36885476 |
| 121 | MP0008873_increased_physiological_sensi | 0.36852462 |
| 122 | MP0002970_abnormal_white_adipose | 0.36554526 |
| 123 | MP0003638_abnormal_response/metabolism_ | 0.36421685 |
| 124 | MP0002822_catalepsy | 0.36284664 |
| 125 | MP0008874_decreased_physiological_sensi | 0.36263413 |
| 126 | MP0005452_abnormal_adipose_tissue | 0.35250649 |
| 127 | MP0005464_abnormal_platelet_physiology | 0.35070311 |
| 128 | MP0009672_abnormal_birth_weight | 0.34386141 |
| 129 | MP0005248_abnormal_Harderian_gland | 0.34280288 |
| 130 | MP0005423_abnormal_somatic_nervous | 0.32918558 |
| 131 | MP0003436_decreased_susceptibility_to | 0.32897261 |
| 132 | MP0000230_abnormal_systemic_arterial | 0.32295912 |
| 133 | MP0009115_abnormal_fat_cell | 0.31988768 |
| 134 | MP0003950_abnormal_plasma_membrane | 0.31731415 |
| 135 | MP0001542_abnormal_bone_strength | 0.31410933 |
| 136 | MP0004742_abnormal_vestibular_system | 0.31380710 |
| 137 | MP0001186_pigmentation_phenotype | 0.30782492 |
| 138 | MP0006082_CNS_inflammation | 0.30653319 |
| 139 | MP0001881_abnormal_mammary_gland | 0.30630645 |
| 140 | MP0001853_heart_inflammation | 0.30492770 |
| 141 | MP0000465_gastrointestinal_hemorrhage | 0.29939762 |
| 142 | MP0000467_abnormal_esophagus_morphology | 0.29501903 |
| 143 | MP0001905_abnormal_dopamine_level | 0.29145246 |
| 144 | MP0002098_abnormal_vibrissa_morphology | 0.27995078 |
| 145 | MP0005275_abnormal_skin_tensile | 0.27692357 |
| 146 | MP0003959_abnormal_lean_body | 0.27668532 |
| 147 | MP0009780_abnormal_chondrocyte_physiolo | 0.26553286 |
| 148 | MP0004264_abnormal_extraembryonic_tissu | 0.26286976 |
| 149 | MP0001849_ear_inflammation | 0.25475990 |
| 150 | MP0003763_abnormal_thymus_physiology | 0.24540515 |
| 151 | MP0001340_abnormal_eyelid_morphology | 0.23703958 |
| 152 | MP0002282_abnormal_trachea_morphology | 0.21368927 |
| 153 | MP0002111_abnormal_tail_morphology | 0.21259024 |
| 154 | MP0002877_abnormal_melanocyte_morpholog | 0.20384176 |
| 155 | MP0000358_abnormal_cell_content/ | 0.19442266 |
| 156 | MP0003879_abnormal_hair_cell | 0.17189513 |
| 157 | MP0009333_abnormal_splenocyte_physiolog | 0.16896194 |
| 158 | MP0005023_abnormal_wound_healing | 0.16646685 |
| 159 | MP0002009_preneoplasia | 0.16596416 |
| 160 | MP0000685_abnormal_immune_system | 0.15627676 |
| 161 | MP0003699_abnormal_female_reproductive | 0.15303715 |
| 162 | MP0006138_congestive_heart_failure | 0.15038021 |
| 163 | MP0005076_abnormal_cell_differentiation | 0.14368461 |
| 164 | MP0000462_abnormal_digestive_system | 0.13731562 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased IgE level (HP:0003212) | 9.33973351 |
| 2 | Hypotrichosis (HP:0001006) | 9.15187088 |
| 3 | Woolly hair (HP:0002224) | 9.04671408 |
| 4 | Onycholysis (HP:0001806) | 8.89150595 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 8.02750806 |
| 6 | Conjunctival hamartoma (HP:0100780) | 7.35595802 |
| 7 | Abnormal hair laboratory examination (HP:0003328) | 7.14417786 |
| 8 | Deep venous thrombosis (HP:0002625) | 7.09550152 |
| 9 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.98741931 |
| 10 | Palmoplantar hyperkeratosis (HP:0000972) | 6.98730153 |
| 11 | Erythema (HP:0010783) | 6.92064239 |
| 12 | Abnormality of hair growth rate (HP:0011363) | 6.77853950 |
| 13 | Slow-growing hair (HP:0002217) | 6.77853950 |
| 14 | Erythroderma (HP:0001019) | 6.67675267 |
| 15 | Complement deficiency (HP:0004431) | 6.64760410 |
| 16 | Palmar hyperkeratosis (HP:0010765) | 6.61138101 |
| 17 | Prolonged partial thromboplastin time (HP:0003645) | 6.49558572 |
| 18 | Brittle hair (HP:0002299) | 6.46068150 |
| 19 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.43298186 |
| 20 | Xanthomatosis (HP:0000991) | 6.30609970 |
| 21 | Hypobetalipoproteinemia (HP:0003563) | 6.18455612 |
| 22 | Plantar hyperkeratosis (HP:0007556) | 5.71822362 |
| 23 | Congenital ichthyosiform erythroderma (HP:0007431) | 5.63899981 |
| 24 | Hyperlipoproteinemia (HP:0010980) | 5.05851408 |
| 25 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 5.04933569 |
| 26 | Absent eyelashes (HP:0000561) | 4.99886799 |
| 27 | Abnormality of nail color (HP:0100643) | 4.94583857 |
| 28 | Epidermoid cyst (HP:0200040) | 4.87645591 |
| 29 | Abnormality of complement system (HP:0005339) | 4.87603325 |
| 30 | Hamartoma of the eye (HP:0010568) | 4.73560286 |
| 31 | Abnormality of the axillary hair (HP:0100134) | 4.66515357 |
| 32 | Abnormality of secondary sexual hair (HP:0009888) | 4.66515357 |
| 33 | Hyperglycinemia (HP:0002154) | 4.62964797 |
| 34 | Hypolipoproteinemia (HP:0010981) | 4.62376075 |
| 35 | Alopecia of scalp (HP:0002293) | 4.56889239 |
| 36 | Fat malabsorption (HP:0002630) | 4.56659049 |
| 37 | Joint hemorrhage (HP:0005261) | 4.52644947 |
| 38 | Hyperammonemia (HP:0001987) | 4.48063825 |
| 39 | Abnormality of the common coagulation pathway (HP:0010990) | 4.31608980 |
| 40 | Dry hair (HP:0011359) | 4.31232330 |
| 41 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.19887550 |
| 42 | Ketosis (HP:0001946) | 4.14791492 |
| 43 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.06055831 |
| 44 | Nail dystrophy (HP:0008404) | 4.04923749 |
| 45 | Thick nail (HP:0001805) | 4.04053368 |
| 46 | Hypoalphalipoproteinemia (HP:0003233) | 3.96490716 |
| 47 | Sparse eyelashes (HP:0000653) | 3.93060803 |
| 48 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.93017223 |
| 49 | Abnormality of glycine metabolism (HP:0010895) | 3.93017223 |
| 50 | Abnormality of methionine metabolism (HP:0010901) | 3.91837118 |
| 51 | Hyperglycinuria (HP:0003108) | 3.90197217 |
| 52 | Conjugated hyperbilirubinemia (HP:0002908) | 3.87747788 |
| 53 | Hypoglycemic coma (HP:0001325) | 3.86192505 |
| 54 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.85314423 |
| 55 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.83696912 |
| 56 | Abnormality of the intrinsic pathway (HP:0010989) | 3.82990680 |
| 57 | Absent hair (HP:0002298) | 3.64970494 |
| 58 | Abnormal blistering of the skin (HP:0008066) | 3.57837728 |
| 59 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.53290533 |
| 60 | Steatorrhea (HP:0002570) | 3.50608854 |
| 61 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.47389015 |
| 62 | Absent eyebrow (HP:0002223) | 3.42228299 |
| 63 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.39754880 |
| 64 | Fine hair (HP:0002213) | 3.32010075 |
| 65 | Hypercholesterolemia (HP:0003124) | 3.26748901 |
| 66 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.23250452 |
| 67 | Systemic lupus erythematosus (HP:0002725) | 3.21606813 |
| 68 | Hypochromic microcytic anemia (HP:0004840) | 3.21149481 |
| 69 | Hyperbilirubinemia (HP:0002904) | 3.20698247 |
| 70 | Fragile nails (HP:0001808) | 3.08143033 |
| 71 | Palmoplantar keratoderma (HP:0000982) | 3.08124595 |
| 72 | Abnormality of serum amino acid levels (HP:0003112) | 3.06552569 |
| 73 | Myocardial infarction (HP:0001658) | 3.05616319 |
| 74 | Follicular hyperkeratosis (HP:0007502) | 3.01085038 |
| 75 | Skin nodule (HP:0200036) | 3.00927402 |
| 76 | Hepatocellular carcinoma (HP:0001402) | 3.00265663 |
| 77 | Ketoacidosis (HP:0001993) | 2.97541307 |
| 78 | Corneal erosion (HP:0200020) | 2.95905089 |
| 79 | Delayed CNS myelination (HP:0002188) | 2.94264960 |
| 80 | Right ventricular cardiomyopathy (HP:0011663) | 2.92530150 |
| 81 | Abnormality of nucleobase metabolism (HP:0010932) | 2.86064863 |
| 82 | Hypergammaglobulinemia (HP:0010702) | 2.84156049 |
| 83 | Spontaneous abortion (HP:0005268) | 2.77409015 |
| 84 | Acanthosis nigricans (HP:0000956) | 2.70470875 |
| 85 | Acanthocytosis (HP:0001927) | 2.69475902 |
| 86 | Metabolic acidosis (HP:0001942) | 2.63509971 |
| 87 | Neonatal onset (HP:0003623) | 2.62094214 |
| 88 | Abnormal gallbladder morphology (HP:0012437) | 2.57239098 |
| 89 | Abnormality of purine metabolism (HP:0004352) | 2.55402787 |
| 90 | Dicarboxylic aciduria (HP:0003215) | 2.53802273 |
| 91 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.53802273 |
| 92 | Lethargy (HP:0001254) | 2.51261261 |
| 93 | Spastic diplegia (HP:0001264) | 2.50502452 |
| 94 | Cholelithiasis (HP:0001081) | 2.50496007 |
| 95 | Parakeratosis (HP:0001036) | 2.49611467 |
| 96 | Abnormality of the pupil (HP:0000615) | 2.48758003 |
| 97 | Hypohidrosis (HP:0000966) | 2.46958428 |
| 98 | Gout (HP:0001997) | 2.45457186 |
| 99 | Hypoglycemic seizures (HP:0002173) | 2.44076632 |
| 100 | Sensorimotor neuropathy (HP:0007141) | 2.38805330 |
| 101 | Mitral stenosis (HP:0001718) | 2.33779856 |
| 102 | Abnormal gallbladder physiology (HP:0012438) | 2.33672791 |
| 103 | Cholecystitis (HP:0001082) | 2.33672791 |
| 104 | Cerebral edema (HP:0002181) | 2.33002055 |
| 105 | Ridged nail (HP:0001807) | 2.32126931 |
| 106 | Blepharitis (HP:0000498) | 2.31536028 |
| 107 | Milia (HP:0001056) | 2.30408566 |
| 108 | Gangrene (HP:0100758) | 2.29439448 |
| 109 | Sparse scalp hair (HP:0002209) | 2.28100094 |
| 110 | Vascular calcification (HP:0004934) | 2.23035536 |
| 111 | Irritability (HP:0000737) | 2.22599911 |
| 112 | Brushfield spots (HP:0001088) | 2.19256301 |
| 113 | Pancreatitis (HP:0001733) | 2.15390485 |
| 114 | Malnutrition (HP:0004395) | 2.14617886 |
| 115 | Hamartoma (HP:0010566) | 2.13045382 |
| 116 | Congenital, generalized hypertrichosis (HP:0004540) | 2.12447103 |
| 117 | Abnormality of the gallbladder (HP:0005264) | 2.12389567 |
| 118 | Amyloidosis (HP:0011034) | 2.12378936 |
| 119 | Esophageal varix (HP:0002040) | 2.05201309 |
| 120 | Enlarged kidneys (HP:0000105) | 2.05002345 |
| 121 | Melanocytic nevus (HP:0000995) | 2.03744867 |
| 122 | Gingival bleeding (HP:0000225) | 2.01118318 |
| 123 | Abnormal cartilage morphology (HP:0002763) | 2.00231091 |
| 124 | Pili torti (HP:0003777) | 10.5290603 |
| 125 | Vomiting (HP:0002013) | 1.99062920 |
| 126 | Glomerulonephritis (HP:0000099) | 1.99057085 |
| 127 | Opisthotonus (HP:0002179) | 1.98774372 |
| 128 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.98749123 |
| 129 | Cardiovascular calcification (HP:0011915) | 1.97962637 |
| 130 | Hemorrhage of the eye (HP:0011885) | 1.96739061 |
| 131 | Late onset (HP:0003584) | 1.96496209 |
| 132 | Renal cortical cysts (HP:0000803) | 1.96075940 |
| 133 | Rickets (HP:0002748) | 1.95738152 |
| 134 | Generalized aminoaciduria (HP:0002909) | 1.95385307 |
| 135 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.94426529 |
| 136 | Pruritus (HP:0000989) | 1.93507641 |
| 137 | Coarse hair (HP:0002208) | 1.90778616 |
| 138 | Thrombophlebitis (HP:0004418) | 1.90613439 |
| 139 | Hyperhidrosis (HP:0000975) | 1.90152151 |
| 140 | Elevated hepatic transaminases (HP:0002910) | 1.85196920 |
| 141 | Menorrhagia (HP:0000132) | 1.84845524 |
| 142 | Poikilocytosis (HP:0004447) | 1.83006011 |
| 143 | Abnormality of iron homeostasis (HP:0011031) | 1.78980541 |
| 144 | Abnormality of the salivary glands (HP:0010286) | 1.77975252 |
| 145 | Elevated alkaline phosphatase (HP:0003155) | 1.76312514 |
| 146 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.76231965 |
| 147 | Hyperglycemia (HP:0003074) | 1.76063727 |
| 148 | Oral leukoplakia (HP:0002745) | 1.74256646 |
| 149 | Advanced eruption of teeth (HP:0006288) | 1.73145619 |
| 150 | Abnormality of vitamin metabolism (HP:0100508) | 1.71589315 |
| 151 | Status epilepticus (HP:0002133) | 1.69598567 |
| 152 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.68293032 |
| 153 | Fatigable weakness (HP:0003473) | 1.67561405 |
| 154 | Abnormality of the neuromuscular junction (HP:0003398) | 1.67561405 |
| 155 | Abnormal biliary tract physiology (HP:0012439) | 1.67098294 |
| 156 | Bile duct proliferation (HP:0001408) | 1.67098294 |
| 157 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.65630433 |
| 158 | Hydroxyprolinuria (HP:0003080) | 1.65054330 |
| 159 | Urticaria (HP:0001025) | 1.60738518 |
| 160 | Abnormality of the dental root (HP:0006486) | 1.59103496 |
| 161 | Taurodontia (HP:0000679) | 1.59103496 |
| 162 | Abnormality of permanent molar morphology (HP:0011071) | 1.59103496 |
| 163 | Skin ulcer (HP:0200042) | 1.56920632 |
| 164 | Lip pit (HP:0100267) | 1.56639949 |
| 165 | Natal tooth (HP:0000695) | 1.55842001 |
| 166 | Abnormality of molar (HP:0011077) | 1.51504363 |
| 167 | Abnormality of molar morphology (HP:0011070) | 1.51504363 |
| 168 | Neonatal death (HP:0003811) | 1.43578054 |
| 169 | Septate vagina (HP:0001153) | 1.43239568 |
| 170 | Nasolacrimal duct obstruction (HP:0000579) | 1.38029802 |
| 171 | Abnormality of the dental pulp (HP:0006479) | 1.37258669 |
| 172 | Eczematoid dermatitis (HP:0000976) | 1.29310464 |
| 173 | Conical tooth (HP:0000698) | 1.25566764 |
| 174 | Ventricular tachycardia (HP:0004756) | 1.20892936 |
| 175 | Oligodontia (HP:0000677) | 1.19675940 |
| 176 | Dry skin (HP:0000958) | 1.19350635 |
| 177 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.19185563 |
| 178 | Aplasia of the phalanges of the hand (HP:0009802) | 1.19185563 |
| 179 | Aplasia involving bones of the extremities (HP:0009825) | 1.19185563 |
| 180 | Furrowed tongue (HP:0000221) | 1.18493918 |
| 181 | Ectropion (HP:0000656) | 1.18479021 |
| 182 | Breast hypoplasia (HP:0003187) | 1.13008824 |
| 183 | Abnormality of alanine metabolism (HP:0010916) | 1.12655854 |
| 184 | Hyperalaninemia (HP:0003348) | 1.12655854 |
| 185 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.12655854 |
| 186 | Papilloma (HP:0012740) | 1.12060690 |
| 187 | Verrucae (HP:0200043) | 1.12060690 |
| 188 | Split foot (HP:0001839) | 1.09960922 |
| 189 | Hypertriglyceridemia (HP:0002155) | 1.09217906 |
| 190 | Generalized hyperpigmentation (HP:0007440) | 1.08783109 |
| 191 | Abnormality of the costochondral junction (HP:0000919) | 1.08415123 |
| 192 | Multifactorial inheritance (HP:0001426) | 1.08176504 |
| 193 | Ulnar claw (HP:0001178) | 1.07970534 |
| 194 | Limb dystonia (HP:0002451) | 1.06487055 |
| 195 | Abnormality of placental membranes (HP:0011409) | 1.05918672 |
| 196 | Amniotic constriction ring (HP:0009775) | 1.05918672 |
| 197 | Skin rash (HP:0000988) | 1.05862613 |
| 198 | Selective tooth agenesis (HP:0001592) | 1.04894270 |
| 199 | Duplicated collecting system (HP:0000081) | 1.04704367 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.68001085 |
| 2 | ERN1 | 4.73643467 |
| 3 | FGFR4 | 4.53452853 |
| 4 | EEF2K | 4.44816040 |
| 5 | MAPKAPK3 | 4.42829561 |
| 6 | SIK1 | 4.12910080 |
| 7 | ERBB4 | 4.03774606 |
| 8 | TAOK3 | 3.17272605 |
| 9 | TGFBR1 | 3.07408031 |
| 10 | INSRR | 2.93018050 |
| 11 | STK24 | 2.60454918 |
| 12 | MAP3K9 | 2.49985732 |
| 13 | MAP2K4 | 2.32435693 |
| 14 | MAPK11 | 2.28002142 |
| 15 | MST1R | 2.16695346 |
| 16 | ARAF | 2.07702212 |
| 17 | EPHB2 | 2.07074132 |
| 18 | MYLK | 2.06218182 |
| 19 | PIK3CG | 2.06179693 |
| 20 | MAP3K12 | 2.04238227 |
| 21 | LATS1 | 1.94638606 |
| 22 | KSR2 | 1.89866332 |
| 23 | MAPKAPK5 | 1.86942860 |
| 24 | RPS6KB2 | 1.76253432 |
| 25 | MAP3K2 | 1.71132915 |
| 26 | PRPF4B | 1.70157757 |
| 27 | TRIB3 | 1.68312420 |
| 28 | TYK2 | 1.64458055 |
| 29 | FGFR2 | 1.57040359 |
| 30 | PKN2 | 1.55771052 |
| 31 | TRPM7 | 1.51150163 |
| 32 | FLT3 | 1.50319301 |
| 33 | ABL2 | 1.47191441 |
| 34 | NEK9 | 1.43857909 |
| 35 | PTK6 | 1.43203761 |
| 36 | MAP3K7 | 1.42005554 |
| 37 | FRK | 1.40748321 |
| 38 | NEK6 | 1.39322458 |
| 39 | DAPK2 | 1.36483755 |
| 40 | ERBB2 | 1.32738061 |
| 41 | JAK2 | 1.32536920 |
| 42 | EPHA2 | 1.32475850 |
| 43 | TESK1 | 1.17571996 |
| 44 | MAPK15 | 1.16076281 |
| 45 | PRKAA2 | 1.15541728 |
| 46 | MAP3K10 | 1.15444003 |
| 47 | BRAF | 1.13822046 |
| 48 | JAK1 | 1.09012833 |
| 49 | KDR | 1.02597350 |
| 50 | PINK1 | 0.98579334 |
| 51 | BRD4 | 0.98083849 |
| 52 | TBK1 | 0.95538164 |
| 53 | MAPK4 | 0.95215462 |
| 54 | PDK2 | 0.93538927 |
| 55 | PAK4 | 0.92024183 |
| 56 | PKN1 | 0.91929445 |
| 57 | STK3 | 0.91227004 |
| 58 | STK38L | 0.90187977 |
| 59 | MAP2K3 | 0.89730190 |
| 60 | MAP3K14 | 0.87686206 |
| 61 | CDK6 | 0.86647979 |
| 62 | GRK6 | 0.86412183 |
| 63 | CAMK1D | 0.86369664 |
| 64 | MET | 0.86355884 |
| 65 | IRAK3 | 0.85413120 |
| 66 | CAMK2G | 0.85089887 |
| 67 | LRRK2 | 0.84858844 |
| 68 | PRKCZ | 0.84731193 |
| 69 | CDK19 | 0.82352916 |
| 70 | BUB1 | 0.81341739 |
| 71 | TIE1 | 0.79968930 |
| 72 | MAPK12 | 0.79589598 |
| 73 | EPHB1 | 0.79035294 |
| 74 | STK39 | 0.77166277 |
| 75 | EPHA3 | 0.76602793 |
| 76 | RPS6KB1 | 0.75055200 |
| 77 | PRKACG | 0.74133575 |
| 78 | MOS | 0.73816484 |
| 79 | PRKAA1 | 0.73394938 |
| 80 | MAP3K3 | 0.72705786 |
| 81 | FGFR3 | 0.72086343 |
| 82 | ILK | 0.71994971 |
| 83 | KSR1 | 0.71484990 |
| 84 | CDK7 | 0.65621286 |
| 85 | GSK3A | 0.65049965 |
| 86 | CDK9 | 0.64844173 |
| 87 | MAP2K6 | 0.63298192 |
| 88 | DYRK1B | 0.63229856 |
| 89 | IKBKB | 0.62051847 |
| 90 | MAPKAPK2 | 0.61600702 |
| 91 | RIPK1 | 0.59675352 |
| 92 | SGK3 | 0.57721258 |
| 93 | CDK12 | 0.57313385 |
| 94 | MAP3K11 | 0.57294540 |
| 95 | RAF1 | 0.56443207 |
| 96 | AURKB | 0.56308112 |
| 97 | MAPK7 | 0.56249682 |
| 98 | NTRK2 | 0.56201987 |
| 99 | PDPK1 | 0.55190115 |
| 100 | MST4 | 0.55025940 |
| 101 | CSNK1G1 | 0.54037412 |
| 102 | MAP3K8 | 0.53508028 |
| 103 | MARK2 | 0.52812536 |
| 104 | CSF1R | 0.52347128 |
| 105 | CHUK | 0.50555231 |
| 106 | RPS6KA4 | 0.49791516 |
| 107 | PTK2 | 0.49746869 |
| 108 | YES1 | 0.48404262 |
| 109 | LATS2 | 0.48334771 |
| 110 | PDGFRA | 0.48021993 |
| 111 | PRKCQ | 0.47831344 |
| 112 | MAP2K1 | 0.46670888 |
| 113 | CSK | 0.44430118 |
| 114 | TTK | 0.44397397 |
| 115 | ERBB3 | 0.43315369 |
| 116 | IGF1R | 0.43079361 |
| 117 | CAMK1G | 0.42432310 |
| 118 | MAP3K6 | 0.42211140 |
| 119 | TGFBR2 | 0.41615329 |
| 120 | IKBKE | 0.41441634 |
| 121 | ICK | 0.41145573 |
| 122 | EIF2AK3 | 0.41118245 |
| 123 | MINK1 | 0.40968415 |
| 124 | EGFR | 0.40628391 |
| 125 | SGK2 | 0.40275484 |
| 126 | MAP3K5 | 0.40067843 |
| 127 | SIK2 | 0.39566516 |
| 128 | MTOR | 0.39255204 |
| 129 | PDK3 | 0.38510557 |
| 130 | PDK4 | 0.38510557 |
| 131 | MAP3K1 | 0.37858219 |
| 132 | RET | 0.37233599 |
| 133 | GRK1 | 0.36850233 |
| 134 | MAP3K13 | 0.35857656 |
| 135 | DYRK3 | 0.35674936 |
| 136 | PRKCG | 0.35617574 |
| 137 | PRKCH | 0.35512481 |
| 138 | IRAK1 | 0.34936075 |
| 139 | CDK4 | 0.34245884 |
| 140 | TYRO3 | 0.32880901 |
| 141 | CSNK1G3 | 0.31474213 |
| 142 | PRKCI | 0.31235235 |
| 143 | PAK1 | 0.31193858 |
| 144 | CSNK1G2 | 0.31187942 |
| 145 | CAMK1 | 0.31182826 |
| 146 | MAPK13 | 0.31091745 |
| 147 | LMTK2 | 0.30425327 |
| 148 | NTRK3 | 0.30392026 |
| 149 | PAK3 | 0.30355917 |
| 150 | PDK1 | 0.30059828 |
| 151 | CSNK1E | 0.29760268 |
| 152 | PBK | 0.28477106 |
| 153 | BMX | 0.27824273 |
| 154 | CAMK4 | 0.27608332 |
| 155 | ABL1 | 0.27040122 |
| 156 | FER | 0.27035034 |
| 157 | SGK494 | 0.27010989 |
| 158 | SGK223 | 0.27010989 |
| 159 | CSNK1A1L | 0.25929405 |
| 160 | PRKCA | 0.24753411 |
| 161 | FGFR1 | 0.23795773 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 5.07704218 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.42325040 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.25268147 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.02028706 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.93148150 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.83883625 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.78800319 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.69931323 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.68475133 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.60501514 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.55680891 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.45434556 |
| 13 | Peroxisome_Homo sapiens_hsa04146 | 2.24471045 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.16253248 |
| 15 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.01913085 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.98259121 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.97216340 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.96393921 |
| 19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.95610058 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.87896728 |
| 21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.84753408 |
| 22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.79257262 |
| 23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.77792649 |
| 24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.73042070 |
| 25 | Retinol metabolism_Homo sapiens_hsa00830 | 1.73010870 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.71870756 |
| 27 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.71607697 |
| 28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.65782824 |
| 29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.64763218 |
| 30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.64094351 |
| 31 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.58787986 |
| 32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.55450157 |
| 33 | Phototransduction_Homo sapiens_hsa04744 | 1.53136239 |
| 34 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.52104803 |
| 35 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.51756649 |
| 36 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.50908824 |
| 37 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.47849515 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.44970846 |
| 39 | Bile secretion_Homo sapiens_hsa04976 | 1.43473741 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.38135755 |
| 41 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.33892853 |
| 42 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.33148621 |
| 43 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.33019866 |
| 44 | * Fatty acid elongation_Homo sapiens_hsa00062 | 1.25964604 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.25697687 |
| 46 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.22307825 |
| 47 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.22021137 |
| 48 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.20585138 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 1.18376741 |
| 50 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.17698313 |
| 51 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.16982249 |
| 52 | Carbon metabolism_Homo sapiens_hsa01200 | 1.14386407 |
| 53 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.13381019 |
| 54 | Alcoholism_Homo sapiens_hsa05034 | 1.04728509 |
| 55 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.03838721 |
| 56 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.99641088 |
| 57 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.99009712 |
| 58 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.94960948 |
| 59 | Sulfur relay system_Homo sapiens_hsa04122 | 0.94664728 |
| 60 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.92060144 |
| 61 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.90713847 |
| 62 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.85549946 |
| 63 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.85367078 |
| 64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.85240410 |
| 65 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.83613641 |
| 66 | Lysine degradation_Homo sapiens_hsa00310 | 0.79724112 |
| 67 | Prion diseases_Homo sapiens_hsa05020 | 0.75510338 |
| 68 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.73875068 |
| 69 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.73850868 |
| 70 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.72661316 |
| 71 | Renin secretion_Homo sapiens_hsa04924 | 0.72196602 |
| 72 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.70826007 |
| 73 | Long-term depression_Homo sapiens_hsa04730 | 0.70292256 |
| 74 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70141756 |
| 75 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.69330201 |
| 76 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.69161197 |
| 77 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.67364864 |
| 78 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.64786025 |
| 79 | Thyroid cancer_Homo sapiens_hsa05216 | 0.63051111 |
| 80 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.62054413 |
| 81 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.58266573 |
| 82 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.52792670 |
| 83 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.51620861 |
| 84 | Circadian rhythm_Homo sapiens_hsa04710 | 0.50182782 |
| 85 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.50000343 |
| 86 | Lysosome_Homo sapiens_hsa04142 | 0.48384941 |
| 87 | Long-term potentiation_Homo sapiens_hsa04720 | 0.45982132 |
| 88 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45561144 |
| 89 | Olfactory transduction_Homo sapiens_hsa04740 | 0.44377402 |
| 90 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.43763612 |
| 91 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.42610740 |
| 92 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.41852576 |
| 93 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.41332686 |
| 94 | Glioma_Homo sapiens_hsa05214 | 0.40607759 |
| 95 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.39612196 |
| 96 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.39216272 |
| 97 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.38642195 |
| 98 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.37456712 |
| 99 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.37278931 |
| 100 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.36975624 |
| 101 | Phagosome_Homo sapiens_hsa04145 | 0.33535816 |
| 102 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.33424780 |
| 103 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.31722682 |
| 104 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.31243906 |
| 105 | Melanogenesis_Homo sapiens_hsa04916 | 0.30874524 |
| 106 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.30493189 |
| 107 | Pertussis_Homo sapiens_hsa05133 | 0.29530645 |
| 108 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.28245109 |
| 109 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.25425812 |
| 110 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24998364 |
| 111 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.24711457 |
| 112 | Insulin resistance_Homo sapiens_hsa04931 | 0.24450074 |
| 113 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.24143797 |
| 114 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.23276549 |
| 115 | Salivary secretion_Homo sapiens_hsa04970 | 0.21710006 |
| 116 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.21681630 |
| 117 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.21229911 |
| 118 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.20508418 |
| 119 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.19182890 |
| 120 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.17476934 |
| 121 | Malaria_Homo sapiens_hsa05144 | 0.16930824 |
| 122 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.16841381 |
| 123 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.14601194 |
| 124 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.12423738 |
| 125 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.11618002 |
| 126 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.10695244 |
| 127 | Tuberculosis_Homo sapiens_hsa05152 | 0.10455533 |
| 128 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01389756 |
| 129 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2424412 |
| 130 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2297363 |
| 131 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2254710 |
| 132 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.2209002 |
| 133 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2006448 |
| 134 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1987646 |
| 135 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1860669 |
| 136 | Bladder cancer_Homo sapiens_hsa05219 | -0.1731476 |
| 137 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1557853 |
| 138 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1547715 |
| 139 | Hepatitis C_Homo sapiens_hsa05160 | -0.1496942 |
| 140 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1426538 |
| 141 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1291066 |
| 142 | Amoebiasis_Homo sapiens_hsa05146 | -0.1180385 |
| 143 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1112143 |
| 144 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0984815 |
| 145 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0965210 |
| 146 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0751031 |
| 147 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0522194 |
| 148 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0484573 |
| 149 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0456996 |

